Prime Medicine, Inc. Common Stock (PRME) — Net Asset Quality Index
Prime Medicine, Inc. Common Stock (PRME) has a Net Asset Quality Index of 26.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $294.73 Million minus total liabilities of $218.03 Million yields net assets of $76.70 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Prime Medicine, Inc. Common Stock (PRME) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Prime Medicine, Inc. Common Stock Net Asset Quality Index Over Time (2019–2025)
This chart shows how Prime Medicine, Inc. Common Stock's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 26.0%, representing net assets of $76.70 Million against total assets of $294.73 Million USD. See Prime Medicine, Inc. Common Stock (PRME) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Prime Medicine, Inc. Common Stock (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Prime Medicine, Inc. Common Stock from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Prime Medicine, Inc. Common Stock worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 35.3% | $120.87 Million | $342.73 Million | $221.87 Million | ▼ -16.2 pp |
| 2024 | 51.5% | $153.15 Million | $297.51 Million | $144.36 Million | ▼ -17.2 pp |
| 2023 | 68.6% | $133.07 Million | $193.85 Million | $60.78 Million | ▼ -19.1 pp |
| 2022 | 87.8% | $316.27 Million | $360.31 Million | $44.04 Million | ▲ +8.4 pp |
| 2021 | 79.4% | $239.56 Million | $301.86 Million | $62.30 Million | ▲ +18.3 pp |
| 2020 | 61.1% | $33.47 Million | $54.78 Million | $21.31 Million | ▲ +45.1 pp |
| 2019 | 16.0% | $1.39 Million | $8.70 Million | $7.31 Million | — |